ZA897580B - Agents for treatment of male impotence - Google Patents

Agents for treatment of male impotence

Info

Publication number
ZA897580B
ZA897580B ZA897580A ZA897580A ZA897580B ZA 897580 B ZA897580 B ZA 897580B ZA 897580 A ZA897580 A ZA 897580A ZA 897580 A ZA897580 A ZA 897580A ZA 897580 B ZA897580 B ZA 897580B
Authority
ZA
South Africa
Prior art keywords
agents
treatment
male impotence
impotence
male
Prior art date
Application number
ZA897580A
Other languages
English (en)
Inventor
Irwin Goldstein
Goldstein Irwin
Inigo Saenz De Tajada
Saenz De Tajada Inigo
Leslie A Riblet
A Riblet Leslie
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA897580B publication Critical patent/ZA897580B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA897580A 1988-10-06 1989-10-05 Agents for treatment of male impotence ZA897580B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/254,346 US4931445A (en) 1988-10-06 1988-10-06 Agents for treatment of male impotence

Publications (1)

Publication Number Publication Date
ZA897580B true ZA897580B (en) 1990-07-25

Family

ID=22963939

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897580A ZA897580B (en) 1988-10-06 1989-10-05 Agents for treatment of male impotence

Country Status (7)

Country Link
US (1) US4931445A (de)
EP (1) EP0362847A3 (de)
JP (1) JP2820737B2 (de)
KR (1) KR0130829B1 (de)
CA (1) CA1338555C (de)
IL (1) IL91865A (de)
ZA (1) ZA897580B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
US5333621A (en) * 1993-05-28 1994-08-02 Eric Denzer Condom with transdermal vasodilator
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
KR100406772B1 (ko) * 2000-05-10 2003-11-22 이영태 점토를 이용한 경량골재
DE102008063728A1 (de) 2008-12-18 2010-06-24 Bayer Materialscience Ag Verfahren zur Herstellung von Isocyanaten in der Gasphase
US20170305842A1 (en) 2014-09-19 2017-10-26 Covestro Deutschland Ag Method for producing isocyanates in the gas phase

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4162318A (en) * 1976-05-05 1979-07-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of trazodone and etoperidone in Parkinsonism and in other extrapyramidal syndromes characterized by tremors
IT1073639B (it) * 1976-05-05 1985-04-17 Acraf Impiego del trazodone e etoperidone nel morbo di parikinson ed in altre sindromi extrapiramidali caratterizzate da tremori
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4131675A (en) * 1978-02-09 1978-12-26 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of combinations of L-DOPA with trazodone and L-DOPA with etoperidone in Parkinsonism
US4687771A (en) * 1985-11-01 1987-08-18 Bristol-Myers Company Method for treatment of male impotence
FR2594335B1 (fr) * 1986-02-14 1991-09-13 Irceba Derives de 5-(2-piperazinoethyl)-thiazole en tant que medicaments utiles en urologie

Also Published As

Publication number Publication date
IL91865A (en) 1993-04-04
US4931445A (en) 1990-06-05
CA1338555C (en) 1996-08-27
KR0130829B1 (ko) 1998-04-23
KR900005974A (ko) 1990-05-07
EP0362847A2 (de) 1990-04-11
JPH02180828A (ja) 1990-07-13
EP0362847A3 (de) 1991-03-27
JP2820737B2 (ja) 1998-11-05

Similar Documents

Publication Publication Date Title
ZA896681B (en) A composition for the treatment of erectile dysfunction
ZA897580B (en) Agents for treatment of male impotence
GB2219503B (en) Treatment of arthritis
AR243138A1 (es) Procedimiento para el tratamiento de un efluente acuoso.
GB8719128D0 (en) Treatment of gas
GB2206341B (en) Treatment of organically-based waste matter
GB8813641D0 (en) Treatment of immunodeficiency
IE883123L (en) Treatment of immunodeficiency
GB8818271D0 (en) Treatment of immunodeficiency
IE861523L (en) Male impotence prosthesis
GR3003007T3 (en) Process for the treatment of alpha-calciumsulphate-hemihydrate
BG46628A1 (en) Means for treatment of artrose alterations
GB8822014D0 (en) Method of treatment
GB8808914D0 (en) Method of treatment
GB8822015D0 (en) Method of treatment
GB8812225D0 (en) Method of treatment
GB8812224D0 (en) Method of treatment
GB8822020D0 (en) Method of treatment
GB8822019D0 (en) Method of treatment
GB8822016D0 (en) Method of treatment
GB8803008D0 (en) Method of treatment
GB8822013D0 (en) Method of treatment
GB8822012D0 (en) Method of treatment
GB8819544D0 (en) Method of treatment
GB8816408D0 (en) Method of treatment